Mode
Text Size
Log in / Sign up
N/A N=30 Diagnostic

Atrial Natriuretic Peptide in Assessing Fluid Status

Fluid Overload · Fluid Loss · Volume Overload · Cardiac Disease · Cardiac Output, Low

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Number of Patients With Pro-ANP Twofold Raise by the End of Surgery — 17 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
pro-ANP (Diagnostic_test)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Petrovsky National Research Centre of Surgery
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients With Pro-ANP Twofold Raise by the End of Surgery
17
PRIMARY
Number of Patients With Pro-ANP Increase > 10% by the PLR Maneuver
5
PRIMARY
Number of Patients With Cardiac Index Rise > 10% After Passive Leg Raising Maneuver
5
PRIMARY
Number of Patients With Pro-ANP Increase > 10% by the PLR Maneuver at the End of Surgery
8
SECONDARY
Postoperative Complications
8
SECONDARY
Mortality
SECONDARY
Multiorgan Failure
SECONDARY
Respiratory Failure
SECONDARY
Renal Failure
SECONDARY
Heart Failure
1
SECONDARY
Circulatory Insufficiency
3
SECONDARY
Infection Rate
SECONDARY
Length of Intensive Care Stay
22

Summary

Biomarkers can play a significant role in fluid status assessment intraoperatively.

Eligibility Criteria

Inclusion Criteria

CABG, one-, two valve repair/replacement, ascending aorta, aortic arch replacement, ASD/AVD closure, septal myectomy

Exclusion Criteria

  • Atrial fibrillation, atrial flutter, frequent ventricular and supraventricular arrythmias
  • EFLV 2 st
  • CKD > C3 (GFR 150 ml
  • LV EDV > 250 ml
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05070819). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search